CON

CON

USD

Concentra Group Holdings Parent Inc. Common Stock

$19.320+0.130 (0.677%)

실시간 가격

Healthcare
Medical Care Facilities
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$19.190

고가

$19.380

저가

$19.000

거래량

1.04M

기업 기본 정보

시가총액

2.5B

산업

Medical Care Facilities

국가

United States

거래 통계

평균 거래량

0.99M

거래소

NYQ

통화

USD

52주 범위

저가 $18.545현재가 $19.320고가 $24.315

AI 분석 리포트

마지막 업데이트: 2025년 11월 2일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

Concentra (CON): A Coiled Spring or a Trap? Unpacking the Bullish Signals Against a Backdrop of Debt

Generation Timestamp: November 2, 2025, 2:05 PM EST

Whispers and Shouts: Reading the Tea Leaves in Concentra's Headlines

The news surrounding Concentra is a classic mix of anticipation and validation. First, the entire market is holding its breath for the company's third-quarter results, due after the bell on November 6th. This is a make-or-break moment that will provide a real look under the hood and could easily dictate the stock's direction for the rest of the year.

Looking back a bit, a significant event still echoes. On September 18th, JP Morgan stepped up with an "Overweight" rating and a bold $31 price target. While the stock was trading higher at the time, that target now looks miles away from the current price near $20. This suggests a major Wall Street firm sees a fundamental value in Concentra that the recent market action has completely ignored. The question for investors is whether that gap represents an opportunity or a warning.

The Anatomy of a Pullback: CON's Journey from Summer Highs to an Autumn Floor

The price chart for Concentra tells a story of two distinct chapters. The stock enjoyed a powerful rally through August, climbing from below $20 to a peak just shy of $24. That was a period of clear strength, with buying interest pushing the price steadily higher on increasing volume.

Then September arrived, and the mood shifted dramatically. The stock gave back nearly all its summer gains, tumbling through the month to find a new base of operations in the $20 to $21 range. For the past several weeks, it has been consolidating in this zone. The most recent action shows the price dipping just below the $20 mark, a level that has previously acted as a psychological floor. This price action sets the stage for a critical test: will this floor hold and serve as a launchpad, or will it break?

The Digital Crystal Ball: AI and Technicals Point to a Short-Term Bounce

This is where things get interesting. While the price chart looks bruised, a collection of technical and predictive indicators are flashing green. The system's AI model is forecasting a notable pop in the next few days, starting with a predicted gain of over 2.5%.

This digital forecast is backed by some classic chart signals. We're seeing a bullish MACD crossover, which often points to a shift in momentum from negative to positive. Trading volume has also surged, suggesting a sudden spike in interest. Most importantly, the stock is sitting right on a technical support level. This combination suggests that traders are viewing the recent dip as a buying opportunity.

However, this technical optimism is bumping up against a serious fundamental concern: debt. The company's debt-to-equity ratio is exceptionally high, a risk factor that cannot be overlooked, especially with an earnings report just days away.

The Bottom Line

The data paints a picture of a high-tension, short-term trading setup for investors with a moderate appetite for risk. The confluence of bullish technical signals, positive AI predictions, and a major analyst price target suggests a rebound could be in the cards. The trade is specifically geared for the very short term, a 1-to-2-week window.

A potential strategy could involve entering a position around the $19.90 - $19.99 level. The immediate target for taking profits would be just under $21.00.

This trade is not without its dangers. The company's high debt is a significant red flag, and the upcoming earnings report is a total wildcard. For that reason, a strict stop-loss at $17.93 is essential to manage the risk if the technical support fails to hold and the stock turns south.


Disclaimer: This report is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any security. The analysis is based solely on the structured data provided and may not be comprehensive. Investing in stocks involves risk, including the possible loss of principal. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

관련 뉴스

BusinessWire

Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025

Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra

더 보기
Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025
Analyst Upgrades

JP Morgan Assumes Concentra Group Holdings at Overweight, Announces Price Target of $31

JP Morgan analyst Benjamin Rossi assumes Concentra Group Holdings with a Overweight rating and announces Price Target of $31.

더 보기
JP Morgan Assumes Concentra Group Holdings at Overweight, Announces Price Target of $31

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 11월 10일 오후 06:37

약세중립강세

68.4% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보통
트레이딩 가이드

진입점

$19.32

익절

$20.61

손절

$17.42

핵심 요소

PDI 13.8이(가) ADX 16.2과 함께 MDI 12.9 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($19.30)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(8,997)의 23.6배로 극도로 강력한 매수 압력을 나타냅니다.
MACD -0.0495이(가) 신호선 -0.0493 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기